Low growth, recovery or second wave: the investments to own in each scenario.
The real reason why Fundsmith has done so well, the trust that says ditch growth stocks and buy value, and the pace is picking up for acquisition-fuelled fundraisings.
Investment ideas include a Covid testing specialist enjoying significant success and a high-quality European company on a rare discount.
Shonaid Jemmett-Page, Non Executive Director, bought 30,534 shares in the company on the 1st October 2020 at a price of 1.310000p. The Director now holds...
Gary Bullard, Non Executive Director, has re-invested 209 shares in the company on the 17th September 2020 at a price of 2.801350p. The Director now...
Michael Cunningham, Executive Director, bought 20,000 shares in the company on the 6th October 2020 at a price of 0.460000p. The Director now holds 120,000...